Tubi's Hollywood is High campaign promoted a 2024 TMZ-presented documentary exploring ayahuasca and ketamine therapy through celebrity and scientific voices.
How Tubi Made Hollywood is High a Streaming Culture Moment
Tubi's "Hollywood is High" campaign promotes a 2024 Tubi Original documentary — TMZ Presents: Hollywood Is High — that examines celebrity and scientific perspectives on psychoactive treatments including ayahuasca retreats and ketamine therapy, premiering in the United States on April 20, 2024.
The campaign positions Tubi as a platform willing to engage with complex, culturally charged subject matter that mainstream streaming competitors rarely commission. Published in March 2024 in the United States, the promotional push centres on a single official trailer — "TMZ Presents: Hollywood Is High | Official Trailer | A Tubi Original" — designed to establish the documentary's editorial credibility before its premiere. The April 20 premiere date was not incidental: that date carries a well-understood cultural association with cannabis in American popular culture, and placing a documentary about psychoactive substances on that day signals an awareness of audience sensibility that goes beyond scheduling logistics.
The 53-minute, TV-MA documentary, as listed on tubitv.com, brings together celebrities and scientists to explore the therapeutic potential and documented risks of modern psychoactive treatments. Harvey Levin, the founder of TMZ, appears among the documentary's participants, lending the production a recognisable media identity that bridges entertainment journalism and investigative inquiry. In the United States, where public and legislative conversations around psychedelic-assisted therapy have accelerated significantly in recent years, the campaign arrives at a moment of genuine cultural relevance. Tubi — owned by Fox Corporation following its 2020 acquisition — operates the programme under its Originals banner, staking a content identity distinct from its free, ad-supported streaming peers.
Tubi targets an American audience at the intersection of wellness curiosity, mental health awareness, and celebrity culture. The documentary format, combined with TMZ's brand recognition, gives the campaign a dual audience appeal: viewers drawn to celebrity narrative and those following mainstream coverage of psychedelic-assisted therapy.
In the United States, the free, ad-supported streaming television market has matured into a genuinely competitive landscape. Tubi reported approximately 78 to 80 million monthly active users around 2024, according to streamingmediaglobal.com and tinuiti.com, establishing it as one of the largest FAST platforms operating in the American market. Competitors including Pluto TV, operated by Paramount Global, and The Roku Channel have each invested in original or exclusive programming to differentiate their content libraries. Tubi's decision to commission a documentary under the TMZ brand represents a parallel move — leveraging an existing media property with strong American name recognition rather than building original IP from the ground up.
The strategic logic is straightforward. Ayahuasca and ketamine therapy have moved from fringe cultural references into mainstream American health conversation, appearing in clinical trial coverage, celebrity memoirs, and policy debates. A documentary that frames these substances through the lens of celebrity experience and scientific scrutiny allows Tubi to address that conversation without adopting an advocacy position. According to streamtvinsider.com, North American FAST revenue reached approximately 7.8 billion dollars in 2024, identified as the largest FAST market globally — context that underlines why differentiated original content matters to platforms competing for advertising revenue and viewer loyalty in the United States. The campaign does not attempt broad brand repositioning; it functions as targeted content promotion aimed at an audience already disposed to engage with alternative wellness narratives.
Peach Content is identified as the agency associated with the Hollywood is High campaign, according to clapboard.com. Beyond that attribution, production credits for the campaign — including director, production company, post-production house, music composer, and editor — are not publicly documented in available sources.
What the campaign does demonstrate is a deliberate editorial register. The official trailer — the campaign's single media asset — operates in the tradition of prestige documentary promotion, presenting the subject matter with seriousness rather than sensationalism. That choice matters in a category where psychoactive substances can easily tip into tabloid framing. By leading with the TMZ Presents label, the campaign borrows the brand's established credibility in celebrity journalism while the scientific voices within the trailer provide the evidentiary grounding that makes the documentary's claims legible to a health-curious audience.
Harvey Levin's presence as a participant, noted in the documentary's listing on tubitv.com and imdb.com, anchors the production within TMZ's editorial universe — a move that gives the trailer a ready-made promotional channel through TMZ's own media infrastructure. The April 20 premiere positioning, while simple, constitutes a piece of creative decision-making in its own right: timing a documentary about psychoactive substances to a date culturally coded for cannabis in the United States is a low-cost signal to an audience that rewards cultural fluency. The trailer accumulated 2,677 views and 29 likes on YouTube at the time of campaign submission, per the campaign archive, reflecting the modest reach typical of platform-specific documentary promotion rather than broad consumer advertising. The documentary runs 53 minutes and carries a TV-MA rating, as listed on tubitv.com, indicating the production commits to the material without softening it for general audiences.
No verified third-party performance data for the Hollywood is High campaign — including streaming viewership figures, completion rates, or advertising impact metrics — is publicly available at the time of writing. The campaign was not identified in available records from Cannes Lions, the Effies, The One Show, D&AD, the Clios, the Webby Awards, or WARC Awards, per the campaign research archive.
The campaign earns a Clapboard Score of 63 out of 100. That score reflects a content promotion that executes its brief competently but does not extend beyond it. The structural effectiveness of the campaign rests on three elements: the cultural timing of the April 20 premiere, the borrowed credibility of the TMZ Presents brand, and a documentary subject — ayahuasca, ketamine therapy, and celebrity psychedelic experience — that aligns with a genuine and growing conversation in American public life. What limits the score is the campaign's narrow footprint. A single trailer asset, modest documented YouTube engagement, and no independently verified performance outcomes suggest a promotion built for platform utility rather than cultural impact at scale.
According to digiday.com and digitalcontentnext.org, FAST platforms in the United States continue to compete aggressively for viewer attention and advertiser spend, making the case for original content investment clear — but also raising the bar for what promotional execution must achieve. Hollywood is High meets that bar adequately without surpassing it.
TMZ Presents: Hollywood Is High is a 53-minute Tubi Original documentary. It examines celebrity and scientific perspectives on psychoactive treatments including ayahuasca retreats and ketamine therapy. The programme carries a TV-MA rating and premiered in the United States on April 20, 2024, on the Tubi free streaming platform.
Hollywood is High premiered on Tubi on April 20, 2024. The premiere date carries a well-known cultural association with cannabis in the United States, a deliberate choice that signals audience awareness. The campaign trailer was published in March 2024 ahead of the premiere.
Harvey Levin, the TMZ founder, is among the participants in Hollywood is High, according to listings on tubitv.com and imdb.com. The documentary presents both celebrity accounts and scientific commentary. Peach Content is identified as the agency behind the campaign promotional materials, per clapboard.com.
Hollywood is High is a Tubi Original, available on Tubi — the free, ad-supported streaming service owned by Fox Corporation in the United States. Tubi reported approximately 78 to 80 million monthly active users around 2024, according to streamingmediaglobal.com, making it one of America's largest FAST platforms.
The Hollywood is High campaign receives a Clapboard Score of 63 out of 100. The score reflects competent execution of a content promotion brief, acknowledging the campaign's culturally timed premiere and borrowed TMZ brand credibility, while noting its limited asset footprint and absence of independently verified performance data.
Hollywood is High supports Tubi's push to establish an Originals identity within the competitive US FAST market. By pairing the TMZ brand with documentary subject matter — ayahuasca and ketamine therapy — aligned to mainstream wellness conversations, Tubi signals editorial ambition beyond its free-to-stream catalogue positioning.
.webp)
Creative Collaboration Platform: The Backbone of Modern Creative WorkWhat is a creative collaboration platform?Clapboard defines a creative collaboration platform as the operational core for today’s distributed creative teams. This is not a collection of digital collaboration tools stitched together; Clapboard’s system
Understanding the Creative Production MarketplaceWhat is a Creative Production Marketplace?Clapboard defines a creative production marketplace as a structured ecosystem where brands, agencies, and production talent converge to execute video, advertising, and branded content at scale. Unlike the legacy agency or freelanREAD FULL ARTICLE
The Urgent Need for a Creative Production Operating SystemWhy Traditional Creative Production Models Break DownClapboard sees the creative production landscape shifting under pressure. Content velocity is no longer a buzzword—it’s a mandate. Modern advertising demands relentless output across dozens of channels, each wREAD FULL ARTICLE
.jpg&w=256&q=75)
